Company Overview

Update
Founders:
Andras Forgacs
Headquarters:
San Diego, CA
IPO:
Went Public on Feb 24, 2012
Stock:
NYSEMKT:ONVO
Categories:
Biotechnology

Organovo develops a range of tissue and disease models for medical research and therapeutic applications.

Description

Update

Organovo is focused on delivering breakthrough three-dimensional biology capabilities to create tissue on demand for research and surgical applications. As the first company with a three-dimensional tissue technology that works across tissue types, they are meeting the promise of regenerative medicine to fill unmet medical needs.

Current Team (3)

Update

Funding Rounds (3) - $26.40M

Update

Investors (1)

Update

Offices/Locations (1)

Update
  • Office

    6275 Nancy Ridge Drive

    Suite 110

    San Diego, CA 92121

    USA

Competitors (1)

Update

Images (1)

Update
  • Fcbd3bfddc05261e40302863a34ad012